Blaize, Inc. Announces Approval from NASDAQ to Begin Trading Immediately
January 15, 2025
Technology
-
-
OMNIQ Secures $1M in New Purchase Orders from Key Logistics and Manufacturing Partner
January 14, 2025
-
WISeKey’s Subsidiary, WISeSat.Space to Launch a New-Generation Satellite on January 14, a Significant Milestone in the Creation of a Global Satellite Constellation
January 13, 2025
-
Aditxt’s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform
January 13, 2025
-
Quantum-Si Launches Platinum® Pro: The End-to-End Solution for Deeper Insights in Proteomics
January 13, 2025
-
O2 Czech Republic Launches Allot Solution to Offer Consumer Cybersecurity Services
January 9, 2025
-
Sekur Private Data Partners with Code4CyberSecurity LLC Offering Privacy Communications Packages to VIPs HNWIs and Businesses
January 8, 2025
-
Perfect Corp. Completes Acquisition of Wannaby, Strengthening Its Market Position in Luxury Fashion Tech
January 8, 2025
-
Windtree Therapeutics Announces New Corporate Strategy Seeking to Identify and Acquire FDA-Approved Revenue Assets While Advancing Its Cardiovascular and Oncology Pipeline
January 8, 2025
-
SEALSQ and WISeSat Unite to Launch Six New Generation Satellites in 2025 Equipped with Advanced Post-Quantum Technology
January 7, 2025
-
EzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion
January 7, 2025
-
Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025
January 7, 2025
-
Predictive Oncology Announces Agreement to be Acquired by Renovaro
January 6, 2025
-
Creative Realities Launches AdLogic CPM+, Delivering a Unified Solution for In-Store Retail Media Networks
January 6, 2025
-
Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar
January 3, 2025
-
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®
January 3, 2025